Home				Skin Diseases Drug Development - Y2007 week 02
DATE	SOURCE	OTHER PARTY INVOLVED	INDICATION(S)	HEADLINES - CLICK TO VIEW FULL RELEASE
01/09/07	Aida Pharmaceuticals (CN)	Shanghai Qiaer Biotechnology (CN)	Melanoma	Aida Pharmaceuticals Receives Approval and Commences Phase II Trials of Potential Cancer Treatment
01/08/07	Provectus Pharmaceticals (US)		Melanoma	Provectus Receives Orphan Drug Designation from FDA for Anti-Cancer Agent PV-10 for the Treatment Of Metastatic Melanoma